title: Options to Promote Competitive Generics Markets in the United States.
authors.affiliation: Warren Alpert Medical School of Brown University, Providence, Rhode Island2Harvard Business School, Boston, Massachusetts.
authors.forename: Clay P
authors.initials: CP
authors.lastname: Wiske
authors.affiliation: Harvard Business School, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
authors.forename: Oluwatobi A
authors.initials: OA
authors.lastname: Ogbechie
authors.affiliation: Harvard Business School, Boston, Massachusetts4Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Schulman
mesh_terms: D032982:Contracts; D016527:Drug Costs; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution*; D004465:Economic Competition; D017850:Economics, Pharmaceutical; D040541:Marketing / Q000458:organization & administration*; D014481:United States
chemical_list: D016568:Drugs, Generic